Blood Thinner Pradaxa Results In More FDA Complaints Than Any Other Drug
Since being approved in 2010, the blood thinner Pradaxa has been linked to over 1,100 deaths and over 12,000 serious injuries in the U.S. So says the nonprofit Institute for Safe Medication Practices (ISMP) that monitors Food & Drug Administration (FDA) reports. Prescribed to treat atrial fibrillation, a heart condition that raised the risk of stroke, this blood thinner has been found to have an extremely high risk of causing bleeding. Hidden documents recently exposed by court order in litigation against Boehringer Ingelheim, the German manufacturer of the drug, have suggested the manufacturer knew of the dangers of bleeding, knew that this dangerous risk could be managed with regular blood tests, but chose not to provide warnings and instructions on this issue for fear of hurting sales.
If you or a loved one suffered from a internal bleeding injuries after taking Pradaxa, contact us for a free consultation about your legal rights.